Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Современная сурфактантная терапия у новорожденных
Современная сурфактантная терапия у новорожденных
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Hochheim K. Centralbl Pathol 1903; 14: 537–8.
2. Virchow R. Arch Pathol Anat 1854; 6: 562.
3. von Neergaard K. Z Gesamte Exp Med 1929; 66: 373–94.
4. Clements J. Am J Physiol 1956; 187: 592.
5. Avery M, Mead J. Am J Dis Child 1959; 97: 517–23.
6. Im Hof V, Gehr P, Gerber V et al. Respiration Physiol 1997; 109: 81–93.
7. Bernhard W, Haagsman HP, Tschernig T et al. Am J Respir Cell Mol Biol 1997; 17: 41–50.
8. Creuwels L, van Golde L, Haagsman H. Lung 1997; 175 (1): 39.
9. Kuroki Y, Voelker DR. J Biol Chem 1994; 269: 25943–6.
10. Phetps DS. Appl Cardiopulmon Pathophysiol 1995; 5 (221): 9.
11. Fujiwara T, Maeta H, Chida S et al. Lancet 1980; 1: 55–9.
12. Surfactant Replacement Therapy in Preterm Infants: A European Survey Anton H. van Kaam, Anne P. De Jaegere, Dorine Borensztajn, Peter C. Rimensberger on behalf of the Neovent Study Group Neonatology 2011; 100: 71–7. DOI: 10.1159/000322004.
13. Early CPAP versus Surfactant in Extremely Preterm Infants N. Finer, M.D., Waldemar A. Carlo, M.D., Michele C. Walsh M.D., for the NICHD Neonatal Research Network and the SUPPORT Study Group. The New England Journal of Medicine May 27, 2010; 362; 21.
14. Kattwinkel J, Robinson M, Bloom BT et al. J Perinatol 2004; 24: 360–5.
15. Trevisanuto D, Grazzina N, Ferrarese P et al. Biology of the Neonate 2005; 87: 217–20.
16. Rairkar M, Nutt M, Johnson ME. Pediatr Res 2006; 59: 142.
17. Finer NN, Merritt TA, Bernstein G et al. Pediatr Res 2006; 59 (4840): 138.
18. Surfactant without Intubation in Preterm Infants with Respiratory Distress: First Multi-center Data Kribs A et al. Klin Padiatr 2010; 222: 13–7.
19. Антонов А.Г., Рындин А.Ю. Сурфактант-BL в комплексной терапии респираторных нарушений у новорожденных детей. Общая реаниматология. 2007; 3: 59–64.
20. Володин Н.Н. и др. Использование экзогенного сурфактанта у недоношенных детей при бронхолегочной дисплазии. Вестник РГМУ. 2010; 2: 41–6.
21. Merrill JD, Ballard RA, Cnaan A et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004; 56 (6): 918–26. [Epub: 2004 Oct 20.]
22. Dijk PH, Heikamp A, Piers DA et al. Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition. Intensive Care Med 1997; 23: 456–62.
23. Berggren E, Liljedahl M, Winbladh B et al. and J Schollin Sachsska Hospital, Stockholm; O¨ rebro Medical Centre Hospital, O¨ rebro; Malmo¨ University Hospital3, Malmo¨; Karolinska Hospital4, Stockholm, Sweden. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000; 89: 460±4.
24. Laughon M, Bose C, Moya F et al. for the Surfaxin Study Group. A Pilot Randomized, Controlled Trial of Later Treatment With a Peptide-Containing, Synthetic Surfactant for the Prevention of Bronchopulmonary Dysplasia. Pediatrics 2009; 123 (1). 89–96. Doi:10.1542/10.1542/peds.2007-2680.
25. Finer NN, Merritt TA, Bernstein G et al. E-PAS 2006; 59: 4848.
26. Rangasamy Ramanathan, Maynard R. Rasmussen, Dale R.Gerstmann, Neil Finer, Krishnamurthy Sekarand The North American Study Group. Am J Perinatol 2004; 21: 109–19.
2. Virchow R. Arch Pathol Anat 1854; 6: 562.
3. von Neergaard K. Z Gesamte Exp Med 1929; 66: 373–94.
4. Clements J. Am J Physiol 1956; 187: 592.
5. Avery M, Mead J. Am J Dis Child 1959; 97: 517–23.
6. Im Hof V, Gehr P, Gerber V et al. Respiration Physiol 1997; 109: 81–93.
7. Bernhard W, Haagsman HP, Tschernig T et al. Am J Respir Cell Mol Biol 1997; 17: 41–50.
8. Creuwels L, van Golde L, Haagsman H. Lung 1997; 175 (1): 39.
9. Kuroki Y, Voelker DR. J Biol Chem 1994; 269: 25943–6.
10. Phetps DS. Appl Cardiopulmon Pathophysiol 1995; 5 (221): 9.
11. Fujiwara T, Maeta H, Chida S et al. Lancet 1980; 1: 55–9.
12. Surfactant Replacement Therapy in Preterm Infants: A European Survey Anton H. van Kaam, Anne P. De Jaegere, Dorine Borensztajn, Peter C. Rimensberger on behalf of the Neovent Study Group Neonatology 2011; 100: 71–7. DOI: 10.1159/000322004.
13. Early CPAP versus Surfactant in Extremely Preterm Infants N. Finer, M.D., Waldemar A. Carlo, M.D., Michele C. Walsh M.D., for the NICHD Neonatal Research Network and the SUPPORT Study Group. The New England Journal of Medicine May 27, 2010; 362; 21.
14. Kattwinkel J, Robinson M, Bloom BT et al. J Perinatol 2004; 24: 360–5.
15. Trevisanuto D, Grazzina N, Ferrarese P et al. Biology of the Neonate 2005; 87: 217–20.
16. Rairkar M, Nutt M, Johnson ME. Pediatr Res 2006; 59: 142.
17. Finer NN, Merritt TA, Bernstein G et al. Pediatr Res 2006; 59 (4840): 138.
18. Surfactant without Intubation in Preterm Infants with Respiratory Distress: First Multi-center Data Kribs A et al. Klin Padiatr 2010; 222: 13–7.
19. Антонов А.Г., Рындин А.Ю. Сурфактант-BL в комплексной терапии респираторных нарушений у новорожденных детей. Общая реаниматология. 2007; 3: 59–64.
20. Володин Н.Н. и др. Использование экзогенного сурфактанта у недоношенных детей при бронхолегочной дисплазии. Вестник РГМУ. 2010; 2: 41–6.
21. Merrill JD, Ballard RA, Cnaan A et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004; 56 (6): 918–26. [Epub: 2004 Oct 20.]
22. Dijk PH, Heikamp A, Piers DA et al. Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition. Intensive Care Med 1997; 23: 456–62.
23. Berggren E, Liljedahl M, Winbladh B et al. and J Schollin Sachsska Hospital, Stockholm; O¨ rebro Medical Centre Hospital, O¨ rebro; Malmo¨ University Hospital3, Malmo¨; Karolinska Hospital4, Stockholm, Sweden. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000; 89: 460±4.
24. Laughon M, Bose C, Moya F et al. for the Surfaxin Study Group. A Pilot Randomized, Controlled Trial of Later Treatment With a Peptide-Containing, Synthetic Surfactant for the Prevention of Bronchopulmonary Dysplasia. Pediatrics 2009; 123 (1). 89–96. Doi:10.1542/10.1542/peds.2007-2680.
25. Finer NN, Merritt TA, Bernstein G et al. E-PAS 2006; 59: 4848.
26. Rangasamy Ramanathan, Maynard R. Rasmussen, Dale R.Gerstmann, Neil Finer, Krishnamurthy Sekarand The North American Study Group. Am J Perinatol 2004; 21: 109–19.
Авторы
А.Ю.Рындин, О.В.Ионов, А.Г.Антонов
ФГУ Научный центр акушерства, гинекологии и перинатологии им. В.И.Кулакова Минздравсоцразвития РФ
ФГУ Научный центр акушерства, гинекологии и перинатологии им. В.И.Кулакова Минздравсоцразвития РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.